Past News Releases

According to a new market report "Bioinformatics Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012 - 2018," published by Transparency Market Research, the global bioinformatics market is estimated to reach market size worth USD 9.1 Billion in 2018. The market is forecasted to record double digit growth, with highest revenue contribution from the bioinformatics platforms segment.

The global bioinformatics market, estimated at USD 2.3 billion in 2012 is forecasted to reach a market size of USD 9.1 billion in 2018, at a CAGR of 25.4% from 2012 - 2018. The market growth is driven by rise in applications across various industries. The key contribution to the market demand is from fields such as agriculture biotechnology, pharmaceutical research and development, medical and clinical diagnostics, and other life-sciences related industries.

The bioinformatics platform holds the largest market share and is estimated to account for nearly 50% of the market revenue. The services market currently holds a relatively smaller market share, however is expected to increase considerably over the forecast period. The bioinformatics platform segment is the fastest growing market and is expected to contribute 54% of the total market growth during the same period.

The demand across genomics and wide application in the medical and biological information sector is driving the demand for bioinformatics platforms and services in the global market. The research outsourcing by pharmaceutical giants in the fields involving bioinformatics content is a significant driver of the global bioinformatics market. These companies in efforts to reduce time and cost on R&D activities involved in the development of novel drugs and new applications for existing drugs, are looking for outsourcing services for bioinformatics knowledge and management tools, platforms, and services.

Global market for bioinformatics is expected to reach $8.3 billion over the year 2014 at the CAGR of 24.8% during the forecasted period. With the increasing demands from US and Europe, among all major segments bioinformatics platforms market is expected to have the maximum share. Developing economies like US and Europe are biggest consumers of this market and this trend is supported by increasing demand for sequencing platforms with growing research in the field of life sciences using the techniques like gene expression analysis, protein expression analysis, and sequence analysis.

Bioinformatics have gained high importance in recent years due to its ability to generate rapid clinical research and its variety of applications like molecular science and gene therapy. It makes use of information technology, algorithms, and statistics for integrating biological data. Most pharmaceutical companies are now adopting automated technologies for manufacturing effective drugs and therapies due to rising concerns towards drug safety and strict regulations governing clinical trials for drug discovery. Pharmaceutical companies are focusing on improving the manufacturing process and quality to withstand the current competitive scenario for price escalation and product differentiation.